- By FYH News Team
[ad_1]
Objective:
Indigenous populations have been disproportionately affected during pandemics. We investigated COVID-19 mortality estimates among Indigenous and non-Indigenous populations at national and sub-national levels in Mexico.
Methods:
We obtained data from the Ministry of Health of Mexico on 2,173,036 laboratory-confirmed RT-PCR positive COVID-19 cases and 238,803 deaths. We estimated mortality per 1000-person weeks, mortality rate ratio among Indigenous vs. non-Indigenous groups (RR), and hazard ratio (HR) for COVID-19 deaths across four waves from February 2020 to March 2022. We also assessed differences in the reproduction number (Rt).
Results:
The mortality rate among Indigenous populations of Mexico was 68% higher than that of non-Indigenous groups. Out of 32 federal entities, 23 exhibited higher mortality rates among Indigenous groups (P<0.05 in 13 entities). The fourth wave showed the highest RR (2.40). The crude HR was 1.67 (95% CI: 1.62, 1.72), which decreased to 1.08 (95% CI: 1.04, 1.11) after controlling for other covariates. During the intense fourth wave, the Rt among the two groups was comparable.
Conclusion:
Indigenous status is a significant risk factor for COVID-19 mortality in Mexico. Our findings may reflect disparities in non-pharmaceutical (e.g., handwashing and using facemasks) and COVID-19 vaccination interventions among Indigenous and non-Indigenous populations in Mexico.
Keywords:
COVID-19 mortality; Disparity; Hazard Ratio; Indigenous; Mexico; Reproduction number.
[ad_2]
Source link
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
- Jessica Wilson
- Victor Mejia
- Subash Kafle


















